Evidence map›Paper›PMID 31328273›Full record

ArticleCancer2019

Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004-2015.

John Virostko, Anna Capasso, Thomas E Yankeelov, Boone Goodgame

Open access · greenAbstract read
In one paragraph

Article in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 2 syntheses or guidelines pooled it, 114 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Postoperative outcomes following prehabilitationWorld journal of gastrointestinal surgery · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Baseline characteristics and recruitment for SWOG S1820: altering intake, managing bowel symptoms in survivors of rectal cancer (AIMS-RC).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

John VirostkoDepartment of Diagnostic Medicine, University of Texas at Austin, Austin, Texas.ORCID 0000-0003-3413-8801
Anna CapassoLivestrong Cancer Institutes, University of Texas at Austin, Austin, Texas.
Thomas E YankeelovDepartment of Diagnostic Medicine, University of Texas at Austin, Austin, Texas.
Boone GoodgameLivestrong Cancer Institutes, University of Texas at Austin, Austin, Texas.
Livestrong Foundation · USSeton Healthcare Family · US

Funding

Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant TherapyU01CA142565 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KARCZMAR, GREGORY S., NANDA, RITA · 2010 to 2019
$4.5M
Image Driven Multi-Scale Modeling to Predict Treatment Response in Breast CancerU01CA174706 · NCI · VANDERBILT UNIVERSITY · PI QUARANTA, VITO, YANKEELOV, THOMAS E · 2013 to 2018
$2.5M
Cancer Prevention and Research Institute of Texas RR160005Cancer Prevention and Research Institute of Texas RR160005, RR160093Cancer Prevention and Research Institute of Texas RR160093NCI NIH HHS U01 CA142565NCI NIH HHS U01CA142565NCI NIH HHS U01 CA174706NCI NIH HHS U01CA174706
6 · The paper itself

Abstract

backgroundThe incidence of colorectal cancer (CRC) in adults younger than 50 years has increased in the United States over the past decades according to Surveillance, Epidemiology, and End Results data. National guidelines conflict over beginning screening at the age of 45 or 50 years.

methodsThis was a retrospective study of National Cancer Data Base data from 2004 to 2015. The Cochran-Armitage test for trend was used to assess changes in the proportion of cases diagnosed at an age younger than 50 years.

resultsThis study identified 130,165 patients diagnosed at an age younger than 50 years and 1,055,598 patients diagnosed at the age of 50 years or older. The proportion of the total number of patients diagnosed with CRC at an age younger than 50 years rose (12.2% in 2015 vs 10.0% in 2004; P < .0001). Younger adults presented with more advanced disease (stage III/IV; 51.6% vs 40.0% of those 50 years old or older). Among men, diagnosis at ages younger than 50 years rose only in non-Hispanic whites (P < .0001), whereas among women, Hispanic and non-Hispanic whites had increases in younger diagnoses over time (P < .05). All income quartiles had a proportional increase in younger adults over time (P < .001), with the highest income quartile having the highest proportion of younger cases. The proportion of younger onset CRC cases rose in urban areas (P < .001) but did not rise in rural areas.

conclusionsThe proportion of persons diagnosed with CRC at an age younger than 50 years in the United States has continued to increase over the past decade, and younger adults present with more advanced disease. These data should be considered in the ongoing discussion of screening guidelines.

Indexed as

AdultAge FactorsColorectal NeoplasmsEarly Detection of CancerFemaleHispanic or LatinoHumansIncidenceMaleMass ScreeningMiddle AgedRetrospective StudiesSEER ProgramUnited StatesWhite Peopleagecolorectal cancerdiagnosisNational Cancer Data Base (NCDB)

Identifiers

PMID31328273
PMCPMC6788938
OpenAlexW2962778047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.